REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q4 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $235,000 | -21.4% | 6,900 | +4.5% | 0.31% | -24.1% |
| Q4 2020 | $299,000 | +31.1% | 6,600 | +6.5% | 0.41% | -56.1% |
| Q2 2020 | $228,000 | +13.4% | 6,200 | 0.0% | 0.94% | +1218.3% |
| Q1 2020 | $201,000 | -15.5% | 6,200 | +6.9% | 0.07% | 0.0% |
| Q4 2019 | $238,000 | +15.5% | 5,800 | 0.0% | 0.07% | +2.9% |
| Q3 2019 | $206,000 | -27.2% | 5,800 | +5.5% | 0.07% | -34.9% |
| Q2 2019 | $283,000 | +0.7% | 5,500 | +12.2% | 0.11% | -6.2% |
| Q1 2019 | $281,000 | +19.6% | 4,900 | -12.5% | 0.11% | +1.8% |
| Q4 2018 | $235,000 | – | 5,600 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |